Kezar Life Sciences Filter Stocks by Fundamentals

Key Indicators . Current Asset . Stocks USA . 
Stock . Kezar Life Sciences
KZR Stock  USD 7.34  -0.05  -0.68%   
Kezar Life's reported Current Asset and the formula behind it are documented below with the most recent data. The current value corresponds to the latest disclosed financial data.
=

null

The reported Current Asset for Kezar Life is derived from recent financial disclosures. The dataset is based on disclosed financial information.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Profitability
Analysis
Details
Earnings
Projections
Details

Did You Try This?

Run USA ETFs Now

   

USA ETFs

Find actively traded Exchange Traded Funds (ETF) in USA
All  Next Launch Module

Important Fundamentals

Return On Equity TTM-0.6
Return On Asset TTM-0.3
Current Valuation-14.99 M
Shares Outstanding7.39 M
Shares Owned By Insiders15.78 %
Shares Owned By Institutions61.20 %
Number Of Shares Shorted151.6 K
Price To Earnings TTM-9.34 X
Price To Book TTM0.77 X
Price To Sales TTM7.75 X
Gross Profit TTM-33.76 M
EBITDA TTM-51.37 M
Net Income TTM-56.03 M
Cash And Equivalents TTM306.84 M
Cash Per Share TTM4.49 X
Total Debt TTM2.33 M
Debt To Equity TTM0.04 %
Current Ratio TTM39.64 X
Book Value Per Share TTM9.56 X
Cash Flow From Operations TTM-51.78 M
Short Ratio TTM1.31 X
Earnings Per Share-7.66 X
Target Price6.0
Trailing Beta0.41
Market Capitalization TTM54.6 M
Total Asset TTM76.65 M
Retained Earnings TTM-490.53 M
Working Capital TTM69.16 M
Current Asset TTM74.47 M
Current Liabilities TTM2.18 M
Net Asset76.65 M

Financial Metrics, Fundamentals & Methodology

Kezar Life's core fundamentals cover profitability, capital efficiency, and funding structure. The company is currently operating at a loss. Overall market capitalization tier is micro-cap. In recent filings, Kezar Life reported EPS loss of 7.66, current ratio of 39.64, debt-to-equity of 0.05 as of the latest reporting period.

Kezar Life Sciences metrics draw on periodic company reporting and market reference feeds, standardized for cross-period comparison. Reported income, balance-sheet, and cash-flow fields adhere to GAAP or IFRS presentation rules.

Editorial review and methodology oversight provided by: Vlad Skutelnik, Macroaxis Contributor


 
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.